Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CBD Body Relief is a topical analgesic formulation, typically available as a gel or cream, that combines hemp-derived cannabidiol (CBD) with counter-irritants such as menthol. It is designed to provide localized relief from musculoskeletal pain, including muscle soreness, joint stiffness, and inflammation. The product's efficacy is derived from a multi-target approach: menthol provides an immediate cooling sensation by activating TRPM8 receptors on sensory neurons, while CBD interacts with the peripheral endocannabinoid system, potentially modulating pain signaling and inflammatory cytokine production through its action as a negative allosteric modulator of CB1 and CB2 receptors. As a consumer-grade hemp product, it is widely used for minor aches associated with arthritis, backaches, and physical exertion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CBD Body Relief.